1. Patel YC. Somatostatin and its receptor family.Front Neuroendocrinol 1999; 20: 157–198.
2. Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors usingin situ hybridization.Cancer Res 1994; 54: 3455–3459.
3. Woltering EA, O’Dorisio MS, O’Dorisio TM. The role of radiolabeled somatostatin analogs in the management of cancer patients. In:Principles and Practice of Oncology, PPO Updates, DeVita Jr VT, Hellman S, Rosenberg SA, eds., Vol. 9. Philadelphia; Lippincott-Raven, 1995: 1–16.
4. Reubi JC, Waser B, Schaer JC, Markwalder R. Somatostatin receptors in human prostate and prostate cancer.J Clin Endocrinol Metab 1995; 80: 2806–2814.
5. Nilsson S, Reubi JC, Kalkner KM, Laissue JA, Horisberger U, Olerud C, et al. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualizedin vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.Cancer Res 1995; 55 (Suppl): 5805s-5810s.